News Cue Biopharma, Inc.

Equities

CUE

US22978P1066

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.365 ^USD	-3.19%		-12.50%	-48.30%

Apr. 08	Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024
Apr. 08	North American Morning Briefing : Inflation Data, -2-	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	Apr. 24	GL
Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024	Apr. 08
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights	Apr. 08	GL
North American Morning Briefing : Inflation Data, -2-	Apr. 08	DJ
Cue Biopharma to Host Business Update Call and Webcast	Apr. 02	GL
Cue Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
North American Morning Briefing : Tech in Focus on -2-	Mar. 25	DJ
North American Morning Briefing : Investors -2-	Mar. 18	DJ
Jefferies Starts Cue Biopharma With Buy Rating	Mar. 13	MT
Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium	Feb. 29	GL
Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 06	GL
Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 06	AQ
HPV+ Recurrent/Metastatic Head and Neck Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	Nov. 23	AQ
Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit	Nov. 22	GL
Transcript : Cue Biopharma, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights	Nov. 09	GL
Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November	Nov. 07	GL
Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November	Nov. 07	AQ
Piper Sandler Adjusts Price Target on Cue Biopharma to $8 From $7, Maintains Overweight Rating	Nov. 06	MT
Cue Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cue Biopharma, Inc.

Equities

CUE

US22978P1066

Summary

Filters